Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Dec 6, 2021 8:00 am EST

OPKO Health Announces the Passing of Director Dr. Richard Lerner

Nov 29, 2021 10:25 am EST

BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.

Nov 29, 2021 8:00 am EST

OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference

Oct 28, 2021 4:15 pm EDT

OPKO Health Reports 2021 Third Quarter Business Highlights and Financial Results

Oct 25, 2021 10:57 am EDT

OPKO Health to Report Third Quarter 2021 Financial Results on October 28, 2021

Sep 24, 2021 4:24 pm EDT

Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency

Sep 14, 2021 8:00 am EDT

LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories

Aug 30, 2021 4:17 pm EDT

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients

Aug 30, 2021 9:04 am EDT

OPKO Health to Participate in Two Upcoming Investment Conferences

Aug 26, 2021 9:30 am EDT

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program